Identification and quantitation of an oxidative metabolite of labetalol in sheep: pharmacokinetic and metabolic implications.

A sensitive and selective assay has been developed for the identification and quantitation of 3-amino-1-phenyl butane (3-APB), a metabolite of labetalol, in biological fluids using electron impact gas chromatography/mass-selective detection. Samples were extracted with n-hexane, derivatized with heptafluorobutyric anhydride and chromatographed on a cross-linked fused-silica capillary column. A positive EI spectrum was obtained using a mass-selective detector. Identification of the metabolite was accomplished using an authentic standard; quantitation was performed in the selected ion monitoring mode using ions m/z 345 (M+) and 132. The assay was linear over the calibration range of 0.5-1000 ng of the analyte and the intra-sample coefficients of variation were less than 12% in all cases. The absolute recovery of 3-APB following extraction from urine and bile was found to be 102.9 +/- 4.9% and 98.3 +/- 1.45% (mean +/- SEM) respectively. The minimum quantitation limit of the assay was 0.5 ng ml-1 (approximately 2 pg injected). Application of the assay in a pharmacokinetic-pharmacodynamic study of labetalol in sheep is demonstrated. The metabolite was detected in urine and bile samples obtained from adult non-pregnant sheep following labetalol administration. The cumulative amount of 3-APB excreted in urine over 24 h was found to be 71.55 micrograms in one animal following a 100 mg dose of labetalol. Evidence for biliary excretion, glucuronidation and sulfation of 3-APB was also found.

[1]  D. Rurak,et al.  Pharmacokinetics and pharmacodynamics of labetalol in the pregnant sheep. , 1992, The Journal of pharmacology and experimental therapeutics.

[2]  J. Gal,et al.  Stereospecific gas chromatographic/mass spectrometric assay of the chiral labetalol metabolite 3-amino-1-phenylbutane. , 1991, Biological mass spectrometry.

[3]  T. K. Gerding,et al.  Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[4]  B. R. Kuhnert,et al.  Maternal and neonatal urinary excretion of sulfate and glucuronide ritodrine conjugates , 1988, Clinical pharmacology and therapeutics.

[5]  D. Rurak,et al.  Effects of diphenhydramine in the fetal lamb after maternal or fetal administration. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  E. Sybertz,et al.  Pharmacology of labetalol in experimental animals. , 1983, The American journal of medicine.

[7]  T. Daneshmend,et al.  The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol. , 1982, British journal of clinical pharmacology.

[8]  R. Bland,et al.  The metabolism of labetalol in animals and man. , 1976, Biochemical Society transactions.

[9]  Davis Wm Antagonism of acute amphetamine intoxication by haloperidol and propranolol. , 1974 .

[10]  E. Zalis,et al.  The pathophysiology of acute amphetamine poisoning with pathologic correlation. , 1967, The Journal of pharmacology and experimental therapeutics.

[11]  V. Larsen Die Beziehung zwischen der gefäßverengernden Wirkung und der Weckwirkung sympathicotroper Amine1 , 1938 .